United States & Moderna
22 shared events · Importance 7 · Last updated Aug 24, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
Ergen Dashboard
Regulatory
United States: The U.S. gains a new flu vaccine option, potentially improving public health outcomes for older adults.
Moderna: Moderna received its fourth FDA-approved product and first mRNA flu vaccine, boosting its commercial prospects and validating its mRNA platform.
Aug 05, 2026 · 105 articles
Regulatory
United States: The United States is the primary market for the mFlusiva vaccine, with tens of thousands of Americans dying from influenza annually. The approval of this mRNA vaccine could significantly impact public health strategies and pandemic preparedness within the country.
Moderna: Moderna is the developer of the mFlusiva mRNA flu vaccine, which is currently under review for approval by the United States — Food and Drug Administration. The positive recommendation from the advisory panel is a significant step towards market entry, potentially boosting its stock and market position in the vaccine sector.
Jun 18, 2026 · 28 articles
International
United States: The United States>>> has announced additional aid to the Democratic Republic of the Congo>>> for the Ebola response and has implemented temporary travel bans for non-citizens from affected countries. It also plans to establish a quarantine facility in Kenya>>> for exposed Americans.
Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
Accidents
United States: United States>>> has bolstered precautions, including screening air passengers and suspending visa services, and has provided $13 million in assistance for the response.
Moderna: Moderna is a key partner in the urgent high-level coordination meeting convened by United States — Centers for Disease Control and Prevention, potentially involved in assessing medical countermeasures for the Ebola outbreak.
May 15, 2026 · 446 articles
Business
United States: The U.S. equity market experienced a broad selloff due to rising yields, weak retail earnings, and inflation concerns, reflecting economic headwinds.
Moderna: Moderna fell 23.5% after surging 177% the previous day, making it the biggest decliner in healthcare.
Aug 20, 2026 · 15 articles
Business
United States: The United States is the host country for these unicorn companies, benefiting significantly from immigrant entrepreneurship in its technology and startup sectors.
Moderna: Moderna is an immigrant-founded unicorn company that has gone public since 2016.
Jun 04, 2026 · 6 articles
Tech
United States: The US is the primary market for the treatment, with regulatory approval and healthcare system implications.
Moderna: Moderna is the co-developer of the vaccine and the primary beneficiary, with its stock more than doubling and adding about $40 billion in market value. The trial success validates its mRNA platform and could lead to a new revenue stream, helping the company return to profitability.
Aug 19, 2026 · 108 articles
Tech
United States: The U.S. is the primary location for the trials and has a large Lynch syndrome population, making it a key market for any approved vaccine.
Moderna: Moderna's mRNA technology is being applied to a Lynch syndrome vaccine, potentially opening a new market and reinforcing its position in mRNA therapeutics.
Aug 06, 2026 · 20 articles
Accidents
United States: Major donor and also imposed travel restrictions on travelers from DRC, which could hinder aid delivery. Its policies have mixed effects on the response.
Moderna: Developed an mRNA-based Bundibugyo vaccine candidate, with Phase 1 trials starting in Canada. Its mRNA platform could offer a rapid response to emerging outbreaks.
Mar 09, 2018 · 543 articles
Domestic
United States: Sovereign issuer facing rising debt levels and fiscal concerns. The Treasury's intervention reflects efforts to manage borrowing costs.
Moderna: Soared 150% on positive vaccine trial results, a notable market mover.
Aug 19, 2026 · 127 articles
Accidents
United States: The United States>>> has pledged financial aid and is monitoring the Ebola outbreak, with some of its citizens exposed or infected, but its previous aid cuts and withdrawal from the World Health Organization>>> have been criticized for weakening global health response capacity.
Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.
May 18, 2026 · 505 articles
Tech
United States: United States>>> is one of the countries where patients were enrolled for the KEYNOTE-942 trial, contributing to the global scope of the research. Its involvement highlights its participation in international medical studies and its significant burden of skin cancer cases.
Moderna: As the manufacturer of intismeran, Moderna>>> is a key beneficiary of the positive clinical trial results, which could lead to increased revenue and market share in cancer treatment. The success of intismeran validates Moderna>>>'s mRNA vaccine platform for oncology applications.
Jun 01, 2026 · 6 articles
International
United States: The US is a key party in the conflict and negotiations. Its blockade and military strikes have escalated tensions, but a potential deal could ease energy markets and reduce inflation pressures.
Moderna: Moderna is a pharma company, not directly affected.
Jun 16, 2026 · 349 articles
Business
United States: Country where Palsonify is approved and where most patients reside.
Moderna: Moderna is a partner with Vertex in developing CF treatments for patients not covered by Vertex's CFTR modulators. The acquisition does not directly affect Moderna.
Jul 06, 2026 · 34 articles
Domestic
Moderna: Moderna is named as a donor to Vaccinate Your Family, indicating its financial support for pro-vaccine advocacy, which indirectly benefits its vaccine business.
May 18, 2026 · 7 articles
ERGEN INTELLIGENCE
Explore this relationship live
Track how United States and Moderna interact across events, view sentiment trends, and discover connected entities.
Open Dashboard